Generic placeholder image

Current Spectroscopy and Chromatography

Editor-in-Chief

ISSN (Print): 2950-4910
ISSN (Online): 2950-4902

Research Article

A Statistical-based Stability-Indicating Assay for the Estimation of Salbutamol and Ketotifen using HPLC and HPTLC Methods

Author(s): Manik Ghosh*, Reetu Bandewar, Arijit Mondal, Suddhasattya Dey*, Saptarshy Sarkar, Padma Charan Behera, Sajal Kumar Jha and Sudip Kumar Mandal

Volume 10, 2024

Published on: 22 February, 2024

Article ID: e220224227328 Pages: 13

DOI: 10.2174/0122132406286654240213113940

Price: $65

Abstract

Background: There are very few methods for simultaneously determining a combined dose of SAL and KET.

Objectives: The current study aims to explore accurate, precise, simple, and cost-effective HPLC and HPTLC techniques for the simultaneous assessment of Salbutamol (SAL) and Ketotifen (KET).

Methods: The determination of Salbutamol and Ketotifen was performed by HPLC and HPTLC methods using 280 nm and 258 nm as the determination wavelength, respectively. Methanol was used to dissolve the drug for estimation in HPLC using mobile phase methanol: 10mM di-Potassium hydrogen orthophosphate in the ratio of 55:45 v/v of pH 4 at a flow rate of 1mL/min and in chloroform: toluene: methanol (7: 2: 3 v/v/v) for the estimation in HPTLC. Moreover, a statistical comparison was made between the results obtained through HPLC and HPTLC of Salbutamol (SAL) and Ketotifen (KET) using the Student’s t-test and F-test.

Results: A linear response was observed in the range of 4-24 μg/mL and 2-12 μg/mL, respectively, for SAL and KET for HPLC. R2 was found to be 0.9998 and 0.9999, respectively. For HPTLC, the linear response was observed in the concentration range of 20-120 ng/ spot and 10 - 60 ng/ spot for SAL and KET, respectively. R2 was found to be 0.9988 and 0.9998, respectively. The limit of detection (LOD) for HPLC was estimated as 0.34 μg/ml and 0.10 μg/ml for SAL and KET, respectively, and for the HPTLC method, the LOD was estimated as 4.8 μg/ml and 1.5 μg/ml, respectively. Analysing the marketed formulation by using both methods, SAL and KET within the range of 100 ± 2% were recovered. The results obtained after the estimation of the Mastifen S tablet by applying both methods were according to nominal content. Degradation studies were performed using both methods. It was found that Salbutamol was unstable in hydrolytic, oxidative and thermal degradation, whereas stable in photolytic conditions. Ketotifen was found to be stable in thermal and photolytic conditions and unstable in hydrolytic and oxidative conditions.

Conclusion: The proposed stability indicating HPLC and HPTLC methods for SAL and KET was found to be simple, accurate, and reproducible for quantitative estimation in pharmaceutical dosage form, without interference from the excipients or degradation products from the main drug component.

[1]
Chitlange, S.S.; Chaturvedi, K.K.; Wankhede, S.B. Development and validation of spectrophotometric and HPLC method for the simultaneous estimation of salbutamol sulphate and prednisolone in tablet dosage form. J. Anal. Bioanal. Tech., 2011, 2(117), 2.
[http://dx.doi.org/10.4172/2155-9872.1000117]
[2]
Tripathi, K.D. Essentials of medical pharmacology, 8th ed; Jaypee Brothers Medical Publishers: New Delhi, 2019.
[3]
[4]
Murtaza, G.; Ahmad, M.; Madni, M.A.; Asghar, M.W. A new reverse phase HPLC method with fluorescent detection for the determination of salbutamol sulfate in human plasma. Bull. Chem. Soc. Ethiop., 2009, 23(1), 1-8.
[http://dx.doi.org/10.4314/bcse.v23i1.21292]
[5]
Mishra, A.K.; Kumar, M.; Mishra, A.; Verma, A.; Chattopadhyay, P. Validated UV spectroscopic method for estimation of salbutamol from tablet formulations. Arch. Appl. Sci. Res., 2010, 2(3), 207-211.
[6]
Al-Khazrajy, O.S. Spectrophotometric determination of ketotifen fumarate in pure and pharmaceutical preperations by bromophenol blue reagent. Ibn Al-Haitham J. Pure Appl. Sci., 2016, 24(3)
[7]
Njaria, P.M.; Abuga, K.O.; Kamau, F.N.; Chepkwony, H.K. A versatile HPLC method for the simultaneous determination of bromhexine, guaifenesin, ambroxol, salbutamol/terbutaline, pseudoephedrine, triprolidine, and chlorpheniramine maleate in cough-cold syrups. Chromatographia, 2016, 79(21-22), 1507-1514.
[http://dx.doi.org/10.1007/s10337-016-3158-1]
[8]
Sagathiya, K.; Bagada, H. Development and validation of RP-HPLC and HPTLC method of analysis for simultaneous estimation of ambroxol HCL, Dextromethorphan HBR and Guaifenesin in pharmaceutical cough cold preparation and statistical comparison of developed methods. Int. J. Pharm. Pharm. Sci., 2014, 6, 312-316.
[9]
Maithani, M.; Sahu, S.; Chaudhary, A.K.; Singh, R. Development and validation of a novel RP-HPLC method for simultaneous determination of salbutamol sulfate, guaifenesin, and ambroxol hydrochloride in tablet formulation. J. Liq. Chromatogr. Relat. Technol., 2012, 35(9), 1156-1170.
[http://dx.doi.org/10.1080/10826076.2011.615289]
[10]
Muralidharan, S.; Kumar, J. High performance liquid chromatographic method development and its validation for salbutamol. Br. J. Pharm. Res., 2012, 2(4), 228-237.
[http://dx.doi.org/10.9734/BJPR/2012/1279]
[11]
Ezhava, S.B.; Bhalara, K.D.; Rathod, I.S.; Bhalara, D.D. Simultaneous estimation of salbutamol sulphate and guaiphenesin in their combined liquid dosage form by HPTLC method. Int. J. Pharma Res. Health Sci., 2014, 2(2), 191-196.
[12]
Kamatham, S.S.; Kolli, S.; Joga, D.D.; Vasa, K.R.; Yanamadala, B.D. Simultaneous estimation of salbutamol, ambroxol and guaifenesin in tablet dosage forms by using RP-HPLC. Int. J. Pharm. Res. Biomed. Analys., 2013, 2(3), 01-13.
[13]
Singhvi, I.; Sachdeva, D. Spectrophotometric estimation of ketotifen fumarate from tablet formulations. Indian J. Pharm. Sci., 2009, 71(1), 66-68.
[http://dx.doi.org/10.4103/0250-474X.51964] [PMID: 20177462]
[14]
Ciesielski, W.; Zakrzewski, R.; Złobińska, U. Coulometric titration of ketotifen in tablets. Pharmazie, 2005, 60(3), 237-238.
[PMID: 15801682]
[15]
Joshi, P.R.; Parmar, S.J.; Patel, B.A. Spectrophotometric simultaneous determination of salbutamol sulfate and ketotifen fumarate in combined tablet dosage form by first-order derivative spectroscopy method. Int. J. Spectrosc., 2013, 2013, 1-6.
[http://dx.doi.org/10.1155/2013/589218]
[16]
Semreen, M.H. Optimization and validation of HPLC method for the analysis of ketotifen fumarate in a pharmaceutical formulation. Bull. Pharm. Sci. Assiut, 2005, 28(2), 291-296.
[17]
Yousuf, M.; Ahmad, M.; Usman, M.; Naeem, M.; Khan, B.A.; Khan, M.K. Development and validation of HPLC method for simultaneous determination of Ketotifen Fumarate and Salbutamol Sulfate in bulk and tablets dosage forms. Main Group Chem., 2022, 21(1), 19-27.
[http://dx.doi.org/10.3233/MGC-210064]
[18]
ICH. Q1B, Harmonized tripartite guideline, stability testing: photostability testing of new drug substances and products. Proceedings of the International Conference on Harmonization, Geneva1996.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy